Julia, Marc; Igolen, Jean; and Igolen, Hanne; Recherches en serie indolique. VI Sur quelques tryptamines substitutees Bul. Soc. Chem., France, 1962, pp. 1060-1068. |
Romeo, E., “2-Aryl-3-Indoleglyoxylamides (FGIN-1): A New Class of Potent and Specific Ligands for the Mitochondiral DBI Receptor (MDR)”, The Journal of Pharmacology and Experimental Therapeutics, vol. 262, No. 3, pp. 971-978 (1992). |
Chemical Abstracts, vol. 67, 73028h, 1967, “Fragmentation of N-benzylindoles in Mass Spectrometry”. |
Alemany, A; Alvarez, E.; Lopez, O. And Herraez, M.E.; No. 565—“Inhibiteurs d'enzymes. XII—Preparation de (propargyamino-2-ethyl)-3-indoles”; Bulletin Do La Societe 'Chimique De France, 1974, No. 12, pp. 2883-2888. |
Kollenz, Gert; Labes, Christa; “Indol-Umlagerung von 1-Diphenyl amino-2,3-dihydro-2,3-pyrrolidionen”; Liebigs Ann. Chem.,1975, pp. 1979-1983. |
Kreft, A.; Nelson, J. Et al.; “Structure-activity relationships leading to WY-121,520 a tris aryl type, Nidomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitos”, Issue vol. 39 (1993), pp. C33-C35, ISSN 0065-4299; publ. By Birkhauser Verlag, Basel Switzerland; (Proceeding of the Sixth International Research Assoc., Sep. 20-24, 1992 at White Haven, PA/USA, Ed., D.W. Morgan and A.K. Welton. |
Seilhamer, Jeffery, et al., “Cloning and Recombinant Expression of Phospholipase A2 present in Rheumatoid Arthritic Synovial Fluid”; The Journal of Biological Chemistry, 254:10, Apr. 5, 1989, pp. 5335-5338. |
Kramer, Ruther et al., “Structure and Properties of a Human Non-Pancreatic Phospholipase A2”, The Journal of Biological Chemistry, 264:10, Apr. 5, 1989, pp. 5768-5775. |
Reynolds, et al., “Analysis of Human Synovial Fluid Phospholipase A2 on Short Chain Phosphatidylcholine-Mixed Micelles: Development of a Spectrophotometric Assay Suitable for a Microtiterplate Reader”, Analytical Biochem, 204, pp. 190-197, 1992. |
Rossum, et al., “Cumulative Dose-Response Curves II. Technique for the making of dose response curves in isolated organs and the evaluation of drug parameters,” Arch. Int. Pharmacodyn. 143, No. 34, pp. 299-330, 1963. |
Wald, Douglas R., “Analysis of Dose-Response Relationships”, Dept. Of Pharma., Univ. Of Mass. Med. Center, 145-179 (no date available). |
Andreani, A., et al., “Nonsteroidal Antiinflammatory Agents. 2. Synthesis and Biological Activity of 2-Chlorindolecarboxylic Acids”; Journal of Medicinal Chemistry, vol. 20, No. 10, 1977, pp. 1344-1346. |
Julia, Marc., et al., “No. 208—Recherches en series indolique. XIII. Sur quelques methoxy -5 et. -6 tryptamines”, Bulletin de La Societe Chemique de France, Paris France; 1965, pp. 1411-1417. |
Chemical Abstracts, vol. 1/2 No. 24, Abstract No. 223181s; “Kinetics of hydrolysis of indomethacin and indomethacin ester predrugs in aqueous solution” Jun. 11, 1990, p. 407. |
Chemical Abstracts Service. “Registry Handbook”, Number Section, Registry Numbers (see, CAS RN 6264-33-1) 1965-1971, Publ. American Chemical Society. |
Von K.H. Boltze; O. Brendler, et al., “Chemische Struktur and antiphlogistische Wirkung in der Reihe der substituierten Indol-3-essigsauren,” Arznermittel Forschung Drug Research, vol. 30 (II), No. 8A, 1980, Aluendorf, DE, pp. 1314-1325. |
Dillard, Robert D., et al., Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2-1. Indole-3-acetamides, Journal of Medicinal Chemistry, vol. 39, No. 26, pp. 5119-5136. |
Dillard, Robert D., et al., Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2-2. Indole-3-acetamides with Additional Functionality, Journal of Medicinal Chemistry, vol. 39, No. 26, pp. 5137-5158. |
Draheim, Susan E., et al., Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2-3. Indole-3-glyoxamides, Journal of Medicinal Chemistry, vol. 39, No. 26, pp. 5159-5175. |